SLN Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Silence Therapeutics PLC (SLN) is not a strong buy at the moment for a beginner investor with a long-term focus. The technical indicators show a neutral to bearish trend, options data reflects weak trading sentiment, and the company's financial performance is underwhelming with no significant growth catalysts. Given the lack of positive news, trading signals, or influential trading activity, it is better to hold off on investing in this stock for now.
The MACD is negative and expanding, indicating bearish momentum. RSI is neutral at 29.733, and moving averages are converging, showing no clear trend. The stock is trading near its support level of 5.333, with resistance levels at 6.407 and 7.48.
NULL identified. No recent news or significant insider/hedge fund activity to act as a catalyst.
The company's financials show no YoY revenue growth, a significant net income loss (-11.77M), and declining EPS (-54.55%). Gross margin also dropped by 17.81%. Technical indicators suggest bearish momentum.
In Q4 2025, revenue remained flat YoY at 34,000. Net income was -11.77M, showing no improvement. EPS dropped significantly to -0.15, and gross margin declined to 59.75%. Overall, financial performance is weak.
No recent analyst ratings or price target changes are available for this stock.
